Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MediXall (MDXL) Cash from Operations (2019 - 2024)

MediXall's Cash from Operations history spans 8 years, with the latest figure at 397742.0 for Q3 2024.

  • For Q3 2024, Cash from Operations fell 50.71% year-over-year to 397742.0; the TTM value through Sep 2024 reached 1202274.0, up 26.08%, while the annual FY2023 figure was 1229546.0, 65.47% up from the prior year.
  • Cash from Operations reached 397742.0 in Q3 2024 per MDXL's latest filing, down from 294238.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 201446.0 in Q4 2023 to a low of 1505763.0 in Q2 2021.
  • Average Cash from Operations over 5 years is 768610.32, with a median of 826722.0 recorded in 2020.
  • Peak YoY movement for Cash from Operations: tumbled 82.14% in 2021, then skyrocketed 70.61% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 1327205.0 in 2020, then rose by 25.03% to 994960.0 in 2021, then soared by 39.87% to 598281.0 in 2022, then surged by 66.33% to 201446.0 in 2023, then crashed by 97.44% to 397742.0 in 2024.
  • Per Business Quant, the three most recent readings for MDXL's Cash from Operations are 397742.0 (Q3 2024), 294238.0 (Q2 2024), and 308848.0 (Q1 2024).